These miRNAs appeared to act as tumor suppressors by targeting Insulin-like Growth Factor 1 Receptor (IGF-1R) and Insulin Receptor Substrate 1 (IRS1), often overexpressed in breast cancer. This evidence concerns the gene IRS1 and neoplasm.